{"title":"月桂叶纳米颗粒标准化提取物的药理作用降低褐家鼠(Rattus norvegicus)的血糖水平","authors":"Hadiyanti Hadiyanti, D. Rahmat, C. Chaidir","doi":"10.52434/jfb.v14i1.1980","DOIUrl":null,"url":null,"abstract":"Several studies revealed that Syzygium polyanthum (Wight) Walp, known as bay leaves, has the potential to be used as herbal medicine due to its active compounds including flavonoids. Herbal medicines are chosen to replace synthetic drugs which have side effects on health. However, some active substances of herbal medicines including bay leaves are less soluble in water and have low bioavailability to be absorbed by the intestine is low. A formulation into nanoparticles will provide more effective results. This study aimed to develop a standardized herbal medicine from the bay leaves extract in nanoparticle form with fine quality and efficacious in lowering blood glucose levels. The nanoparticle formulation was conducted using the ionic gelation method with chitosan-tripolyphosphate base and was designed into pre-and post-test-controlled group designs. Wistar white rats ( Rattus norvegicus ) were used as the experimental animal and grouped into a negative control group, normal control group, positive control (Glibenclamide) groups, and test dosages-induced control group. Fasting blood glucose levels were measured using an enzymatic glucometer and the AUC was analyzed based on the trapezoidal formula statistically using the Kruskal-Wallis and Mann-Whitney tests. The results showed that the bay leaves contained secondary metabolite including flavonoid with concentrations at 96%, 70%, 50%, respectively. The nanoparticles sizes were 1.48%; 1.62%; 1.50%; and 0.03%, respectively. The average particle size was 549.2 nm, and the zeta potential was -40.2 mV. Nanoparticle administration at a dose of 426.80 mg/kg BW; 213.40 mg/kg BW; and 106.70 mg/kg BW showed decreasing blood glucose levels when compared to the positive control group but not significant (P>0.005). The smallest dose of nanoparticle extract that lowered blood glucose levels was at a dose of 106.70 mg/kg BW. It can be concluded the nanoparticles form of bay leaves extract can lower blood glucose levels and meets the quality requirements.","PeriodicalId":197039,"journal":{"name":"Jurnal Ilmiah Farmako Bahari","volume":"157 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE EFFECT OF NANOPARTICLE STANDARDIZED EXTRACTS OF BAY LEAVES (Syzygium polyanthum (Wight) Walp.) IN LOWERING BLOOD GLUCOSE LEVELS OF WHITE RATS (Rattus norvegicus)\",\"authors\":\"Hadiyanti Hadiyanti, D. Rahmat, C. Chaidir\",\"doi\":\"10.52434/jfb.v14i1.1980\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Several studies revealed that Syzygium polyanthum (Wight) Walp, known as bay leaves, has the potential to be used as herbal medicine due to its active compounds including flavonoids. Herbal medicines are chosen to replace synthetic drugs which have side effects on health. However, some active substances of herbal medicines including bay leaves are less soluble in water and have low bioavailability to be absorbed by the intestine is low. A formulation into nanoparticles will provide more effective results. This study aimed to develop a standardized herbal medicine from the bay leaves extract in nanoparticle form with fine quality and efficacious in lowering blood glucose levels. The nanoparticle formulation was conducted using the ionic gelation method with chitosan-tripolyphosphate base and was designed into pre-and post-test-controlled group designs. Wistar white rats ( Rattus norvegicus ) were used as the experimental animal and grouped into a negative control group, normal control group, positive control (Glibenclamide) groups, and test dosages-induced control group. Fasting blood glucose levels were measured using an enzymatic glucometer and the AUC was analyzed based on the trapezoidal formula statistically using the Kruskal-Wallis and Mann-Whitney tests. The results showed that the bay leaves contained secondary metabolite including flavonoid with concentrations at 96%, 70%, 50%, respectively. The nanoparticles sizes were 1.48%; 1.62%; 1.50%; and 0.03%, respectively. The average particle size was 549.2 nm, and the zeta potential was -40.2 mV. Nanoparticle administration at a dose of 426.80 mg/kg BW; 213.40 mg/kg BW; and 106.70 mg/kg BW showed decreasing blood glucose levels when compared to the positive control group but not significant (P>0.005). The smallest dose of nanoparticle extract that lowered blood glucose levels was at a dose of 106.70 mg/kg BW. It can be concluded the nanoparticles form of bay leaves extract can lower blood glucose levels and meets the quality requirements.\",\"PeriodicalId\":197039,\"journal\":{\"name\":\"Jurnal Ilmiah Farmako Bahari\",\"volume\":\"157 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Ilmiah Farmako Bahari\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52434/jfb.v14i1.1980\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Ilmiah Farmako Bahari","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52434/jfb.v14i1.1980","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
几项研究表明,月桂叶,即月桂叶,由于其活性成分包括类黄酮,有可能被用作草药。选择草药来代替对健康有副作用的合成药物。然而,包括月桂叶在内的一些草药的活性物质不易溶于水,被肠道吸收的生物利用度较低。制成纳米颗粒的配方将提供更有效的结果。本研究旨在从月桂叶提取物中提取出一种具有优良品质和有效降低血糖水平的纳米颗粒形式的标准化草药。采用壳聚糖-三聚磷酸酯基离子凝胶法制备纳米颗粒,并设计为前后对照组设计。以褐家鼠Wistar white rat (Rattus norvegicus)为实验动物,分为阴性对照组、正常对照组、阳性对照组(格列本脲)组和试验剂量诱导对照组。使用酶促血糖仪测量空腹血糖水平,使用Kruskal-Wallis和Mann-Whitney试验根据梯形公式统计分析AUC。结果表明,月桂叶次生代谢产物黄酮类化合物含量分别为96%、70%和50%。纳米颗粒尺寸为1.48%;1.62%;1.50%;分别为0.03%。平均粒径549.2 nm, zeta电位为-40.2 mV。纳米颗粒给药剂量为426.80 mg/kg BW;213.40 mg/kg BW;与阳性对照组相比,106.70 mg/kg BW组血糖水平降低,但不显著(P>0.005)。纳米颗粒提取物降低血糖水平的最小剂量为106.70 mg/kg BW。由此可见,纳米颗粒形式的月桂叶提取物具有较低的血糖水平,符合质量要求。
THE EFFECT OF NANOPARTICLE STANDARDIZED EXTRACTS OF BAY LEAVES (Syzygium polyanthum (Wight) Walp.) IN LOWERING BLOOD GLUCOSE LEVELS OF WHITE RATS (Rattus norvegicus)
Several studies revealed that Syzygium polyanthum (Wight) Walp, known as bay leaves, has the potential to be used as herbal medicine due to its active compounds including flavonoids. Herbal medicines are chosen to replace synthetic drugs which have side effects on health. However, some active substances of herbal medicines including bay leaves are less soluble in water and have low bioavailability to be absorbed by the intestine is low. A formulation into nanoparticles will provide more effective results. This study aimed to develop a standardized herbal medicine from the bay leaves extract in nanoparticle form with fine quality and efficacious in lowering blood glucose levels. The nanoparticle formulation was conducted using the ionic gelation method with chitosan-tripolyphosphate base and was designed into pre-and post-test-controlled group designs. Wistar white rats ( Rattus norvegicus ) were used as the experimental animal and grouped into a negative control group, normal control group, positive control (Glibenclamide) groups, and test dosages-induced control group. Fasting blood glucose levels were measured using an enzymatic glucometer and the AUC was analyzed based on the trapezoidal formula statistically using the Kruskal-Wallis and Mann-Whitney tests. The results showed that the bay leaves contained secondary metabolite including flavonoid with concentrations at 96%, 70%, 50%, respectively. The nanoparticles sizes were 1.48%; 1.62%; 1.50%; and 0.03%, respectively. The average particle size was 549.2 nm, and the zeta potential was -40.2 mV. Nanoparticle administration at a dose of 426.80 mg/kg BW; 213.40 mg/kg BW; and 106.70 mg/kg BW showed decreasing blood glucose levels when compared to the positive control group but not significant (P>0.005). The smallest dose of nanoparticle extract that lowered blood glucose levels was at a dose of 106.70 mg/kg BW. It can be concluded the nanoparticles form of bay leaves extract can lower blood glucose levels and meets the quality requirements.